Therefore, CD11/CD18 expression was considered as a marker for clinical diagnosis and disease severity of LAD-1 [19–21] and should be used as a first-line diagnostic approach in patients suspected to have LAD disease. Here, ITGB2 is linked to leukocyte adhesion deficiency 1.